Hempacco Co., Inc.
DelistedCIK 1892480fmd_1XZ5838NAMNHMTH9P7QX95NV25Manufacturing · CigarettesTemplate: Standard
Coverage: Jan 01, 2021 to Dec 31, 2023, 10 periods
Latest annual · FY2023
Millions- Total revenues
- 4
- Gross profit
- (1)
- Operating income
- (13)
- Net income
- (13)
- Free cash flow
- (6)
Latest quarter · Q4 FY2023
Millions- Total revenues
- 2
- Gross profit
- (1)
- Operating income
- (7)
- Net income
- (7)
- Free cash flow
- (1)
Hempacco Co., Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $4 million | $4 million | +2% | 10-K 2024-08-09 · proof |
| Gross profit | -$1.2 million | $239,046 | -608.6% | 10-K 2024-08-09 · proof |
| Operating income | -$13.2 million | -$7.1 million | 10-K 2024-08-09 · proof | |
| Net income | -$13.4 million | -$7.1 million | 10-K 2024-08-09 · proof | |
| Cash from operating activities | -$5.8 million | -$4.4 million | 10-K 2024-08-09 · proof | |
| Free cash flow | -$6 million | -$4.5 million | 10-K 2024-08-09 · proof | |
| Total assets | $18 million | $9.5 million | +90.3% | 10-K 2024-08-09 · proof |
| Total liabilities | $18.8 million | $1.9 million | +879.3% | 10-K 2024-08-09 · proof |
| Cash and cash equivalents | $109,825 | $548,331 | -80% | 10-K 2024-08-09 · proof |
- What was Hempacco Co., Inc.'s revenue in fiscal 2023?
- Hempacco Co., Inc. reported revenue of $4 million for fiscal 2023 (the year ended Dec 31, 2023), against $4 million the year before (+2%). Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What was Hempacco Co., Inc.'s gross profit in fiscal 2023?
- Hempacco Co., Inc. reported gross profit of -$1.2 million for fiscal 2023 (the year ended Dec 31, 2023), against $239,046 the year before (-608.6%). Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What was Hempacco Co., Inc.'s operating income in fiscal 2023?
- Hempacco Co., Inc. reported operating income of -$13.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What was Hempacco Co., Inc.'s net income in fiscal 2023?
- Hempacco Co., Inc. reported net income of -$13.4 million for fiscal 2023 (the year ended Dec 31, 2023), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What was Hempacco Co., Inc.'s cash from operating activities in fiscal 2023?
- Hempacco Co., Inc. reported cash from operating activities of -$5.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$4.4 million the year before. Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What was Hempacco Co., Inc.'s free cash flow in fiscal 2023?
- Hempacco Co., Inc. reported free cash flow of -$6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$4.5 million the year before. Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What are Hempacco Co., Inc.'s total assets?
- As of Dec 31, 2023, Hempacco Co., Inc. reported total assets of $18 million, against $9.5 million a year earlier (+90.3%). Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What are Hempacco Co., Inc.'s total liabilities?
- As of Dec 31, 2023, Hempacco Co., Inc. reported total liabilities of $18.8 million, against $1.9 million a year earlier (+879.3%). Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
- What are Hempacco Co., Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Hempacco Co., Inc. reported cash and cash equivalents of $109,825, against $548,331 a year earlier (-80%). Source: the 10-K filed with the SEC on Aug 9, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1892480&period_type=annual&limit=5"Information only, not investment advice.